Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dengue Shock Syndrome”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00875524
What this trial is testing

Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects

Who this might be right for
Dengue VirusDengue FeverDengue Hemorrhagic Fever+1 more
Sanofi Pasteur, a Sanofi Company 180
Testing effectiveness (Phase 2)Study completedNCT00468858
What this trial is testing

Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and Children

Who this might be right for
Dengue FeverDengue Hemorrhagic FeverDengue Shock Syndrome
U.S. Army Medical Research and Development Command 636
Large-scale testing (Phase 3)Study completedNCT02979535
What this trial is testing

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix®

Who this might be right for
Dengue FeverDengue Hemorrhagic FeverHuman Papillomavirus Disease
Sanofi Pasteur, a Sanofi Company 480
Testing effectiveness (Phase 2)Study completedNCT00740155
What this trial is testing

Safety and Immunogenicity of Formulations of Dengue Vaccines in Healthy Flavivirus-Naïve Adults

Who this might be right for
Dengue VirusDengue FeverDengue Hemorrhagic Fever+1 more
Sanofi Pasteur, a Sanofi Company 154
Testing effectiveness (Phase 2)Study completedNCT00880893
What this trial is testing

Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in Singapore

Who this might be right for
Dengue FeverDengue Hemorrhagic FeverDengue Virus+1 more
Sanofi Pasteur, a Sanofi Company 1,198
Early research (Phase 1)Study completedNCT01084291
What this trial is testing

Evaluation of the Safety and Immune Response to an Investigational Dengue Type 1 Vaccine

Who this might be right for
Dengue Virus
National Institute of Allergy and Infectious Diseases (NIAID) 18
Early research (Phase 1)Study completedNCT00270699
What this trial is testing

Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-200,201) in Healthy Adults

Who this might be right for
Dengue Fever
National Institute of Allergy and Infectious Diseases (NIAID) 56
Early research (Phase 1)Study completedNCT01073306
What this trial is testing

Safety and Immune Response to an Investigational Dengue Type 2 Vaccine

Who this might be right for
Dengue Virus
National Institute of Allergy and Infectious Diseases (NIAID) 18
Early research (Phase 1)Study completedNCT00936429
What this trial is testing

Study of HBV-001 D1 in Healthy Adults

Who this might be right for
Dengue Fever
Hawaii Biotech, Inc. 16
Testing effectiveness (Phase 2)Study completedNCT01550289
What this trial is testing

Study of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in India

Who this might be right for
DengueDengue FeverDengue Hemorrhagic Fever
Sanofi Pasteur, a Sanofi Company 189
Testing effectiveness (Phase 2)Study completedNCT00993447
What this trial is testing

Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America

Who this might be right for
DengueDengue Hemorrhagic FeverDengue Virus+1 more
Sanofi Pasteur, a Sanofi Company 600
Testing effectiveness (Phase 2)Study completedNCT01943825
What this trial is testing

Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity After CYD Tetravalent Dengue Vaccine

Who this might be right for
DengueDengue FeverDengue Hemorrhagic Fever
Sanofi Pasteur, a Sanofi Company 90
Post-approval studies (Phase 4)UnknownNCT02673840
What this trial is testing

Ketotifen as a Treatment for Vascular Leakage During Dengue Fever

Who this might be right for
Dengue FeverPleural Effusion
National University Hospital, Singapore 110
Early research (Phase 1)Study completedNCT00458120
What this trial is testing

Safety of and Immune Response to Two Different Dengue Virus Vaccines in Individuals Previously Immunized Against Dengue Virus

Who this might be right for
Dengue Hemorrhagic Fever
National Institute of Allergy and Infectious Diseases (NIAID) 36
Testing effectiveness (Phase 2)Study completedNCT00617344
What this trial is testing

Immunogenicity and Safety of Three Formulations of Dengue Vaccines in Healthy Adults Aged 18 to 45 Years in the US

Who this might be right for
Dengue FeverDengue Hemorrhagic FeverDengue Virus
Sanofi 260
Large-scale testing (Phase 3)Study completedNCT02993757
What this trial is testing

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil®

Who this might be right for
Dengue FeverDengue Hemorrhagic FeverHuman Papillomavirus Disease
Sanofi Pasteur, a Sanofi Company 528
Large-scale testing (Phase 3)Study completedNCT04673422
What this trial is testing

Effect of Montelukast in Preventing Dengue With Warning Signs in Dengue Patients

Who this might be right for
DengueDengue With Warning SignsDengue Shock Syndrome
Phramongkutklao College of Medicine and Hospital 358
Not applicableUnknownNCT04837430
What this trial is testing

NT-proBNP and Troponin I in Dengue Children

Who this might be right for
Dengue Shock SyndromeChildren, Only
Le Phuoc Truyen 90
Testing effectiveness (Phase 2)Study completedNCT00730288
What this trial is testing

Study of ChimeriVax™ Dengue Tetravalent Vaccine in Adult Subjects

Who this might be right for
DengueDengue FeverDengue Hemorrhagic Fever+1 more
Sanofi 35
Testing effectiveness (Phase 2)UnknownNCT06071481
What this trial is testing

Role of Vitamin D in Prevention of Dengue Haemorrhagic Fever and Dengue Shock Syndrome

Who this might be right for
Dengue Fever
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 120
Next Page